Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

BACKGROUND: Preoperative imatinib mesylate (IM) treatment has not yet been standardized. Here, we aim to further explore such therapy on patients with gastrointestinal stromal tumors (GIST) retrospectively. METHODS: Patients experiencing preoperative IM were identified from January 2009 to February...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Surg Oncol
Main Authors: Tang, Sumin, Yin, Yuan, Shen, Chaoyong, Chen, Jiaju, Yin, Xiaonan, Zhang, Bo, Yao, Yuqin, Yang, Jinliang, Chen, Zhixin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387273/
https://ncbi.nlm.nih.gov/pubmed/28399894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-017-1143-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki